Skip to main content
. 2020 Oct 7;26:e926755-1–e926755-22. doi: 10.12659/MSM.926755

Table 1.

Correlation between PKMYT1 mRNA levels and clinicopathological parameters in 530 patients with ccRCC from the TCGA database.

Variable Groups N Low High χ2 P value
Age (years) ≤60 264 129 135 0.27136 0.6024
>60 266 137 129
NA
Sex Male 344 164 180 2.2003 0.138
Female 186 102 84
NA
Race White 459 226 233 0.4298*
Asian 8 4 4
Black 56 33 23
NA 7
Laterality Right 280 148 132 1.5888 0.2075
Left 249 117 132
Bilateral 1
NA
T classification T1 271 149 122 22.122 P<0.0001
T2 69 44 25
T3 179 72 107
T4 11 1 10
TX
NA
N classification N0 239 121 118 4.8908 0.027
N1 16 3 13
NX 275
NA
M classification M0 440 231 209 7.6072 0.0058
M1 80 28 52
MX 10
NA
TNM stage I 265 145 120 14.688 0.0021
II 57 36 21
III 123 55 68
IV 82 29 53
NA 3
Histologic grade G1 14 11 3 19.3 0.0002
G2 227 127 100
G3 206 99 107
G4 75 23 52
NA 8
Tumor status With tumor 138 54 84 8.4434 0.0037
Tumor-free 358 194 164
NA 34
Relapse No 373 202 171 7.3991 0.0065
Yes 157 64 93
NA
Vital status Dead 172 68 104 10.939 0.0009
Alive 358 198 160
NA
*

P value of Fisher’s exact test conducted on a small sample.

mRNA – messenger RNA; ccRCC – clear cell renal cell carcinoma; TCGA – The Cancer Genome Atlas.